• Thurs news: AbbVie Parkinson’s drug. Arch raises $3B biotech fund. Biogen dropping failed Sage tremor drug. AZ gets sought-after Tagrisso OK. Pfizer withdrawing sickle cell med. See more on our front page

#janssen

  1. Tagrisso vs Rybrevant in 1L NSCLC, any thoughts ?

    Any AZ MSL sales reps here, thoughts on what HCPs going to choose?